We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Greenfire Resources
GFR
$916M
| $103K | ﹤0.01% |
18,181
-51,546
| -74% | -$306K |
|
2902
CALL
Mastercard
MA
$500B
| $103K | ﹤0.01% |
200
| – | – |
|
2903
Laird Superfood
LSF
$44.1M
| $102K | ﹤0.01% |
+21,753
| New | +$72.8K |
|
2904
CALL
Charter Communications
CHTR
$17.4B
| $99.5K | ﹤0.01% |
+700
| New | +$117K |
|
|
NTHI
2905
NeOnc Technologies
NTHI
$106M
| $98.7K | ﹤0.01% |
21,784
+9,206
| +73% | +$46K |
|
|
ILLR
2906
Triller Group Inc
ILLR
$16.6M
| $98.6K | ﹤0.01% |
+36,400
| New | +$87K |
|
|
SEVN
2907
Seven Hills Realty Trust
SEVN
$169M
| $98.3K | ﹤0.01% |
+11,664
| New | +$97.3K |
|
|
IMDX
2908
Insight Molecular Diagnostics
IMDX
$140M
| $97.9K | ﹤0.01% |
+16,597
| New | +$81.9K |
|
|
ADAM
2909
Adamas Trust
ADAM
$873M
| $96.2K | ﹤0.01% |
+10,257
| New | +$88.2K |
|
2910
CALL
Viavi Solutions
VIAV
$9.56B
| $95.5K | ﹤0.01% |
2,000
-10,300
| -84% | -$493K |
|
2911
PUT
CVS Health
CVS
$123B
| $93.1K | ﹤0.01% |
+900
| New | +$80.3K |
|
|
RENT
2912
Rent the Runway
RENT
$107M
| $91.1K | ﹤0.01% |
28,919
-56,126
| -66% | -$238K |
|
|
NVX
2913
NOVONIX
NVX
$68.8M
| $90.8K | ﹤0.01% |
19,750
-982
| -5% | -$6.54K |
|
2914
CALL
KLA
KLAC
$247B
| $90.5K | ﹤0.01% |
+300
| New | +$59.6K |
|
2915
KORU Medical Systems
KRMD
$146M
| $90.3K | ﹤0.01% |
21,496
-3,171
| -13% | -$13K |
|
2916
PUT
Ulta Beauty
ULTA
$23.5B
| $90.2K | ﹤0.01% |
200
-74,800
| -100% | -$38M |
|
2917
CALL
Verisk Analytics
VRSK
$22.8B
| $89.8K | ﹤0.01% |
500
| – | – |
|
2918
CALL
Affirm
AFRM
$24.3B
| $89.7K | ﹤0.01% |
1,100
+300
| +38% | +$19.6K |
|
|
NKLR
2919
Terra Innovatum Global N.V.
NKLR
$625M
| $88K | ﹤0.01% |
+17,884
| New | +$101K |
|
2920
CALL
CF Industries
CF
$20.3B
| $86.6K | ﹤0.01% |
800
+100
| +14% | +$11.8K |
|
2921
PUT
Invesco CurrencyShares Euro Currency Trust
FXE
$370M
| $84.4K | ﹤0.01% |
800
+500
| +167% | +$53.7K |
|
2922
CALL
UiPath
PATH
$7.26B
| $83.7K | ﹤0.01% |
7,700
-4,400
| -36% | -$47K |
|
2923
CALL
Kohl's
KSS
$2.11B
| $83.3K | ﹤0.01% |
4,700
-12,200
| -72% | -$181K |
|
2924
Genelux
GNLX
$115M
| $83.2K | ﹤0.01% |
+27,646
| New | +$78.2K |
|
|
DEFT
2925
Defi Technologies
DEFT
$241M
| $82.5K | ﹤0.01% |
+161,822
| New | +$110K |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.